Jacques Tostain
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment
- Renal and Vascular Pathologies
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
Papers in
-
- Renal cell carcinoma treatment 56
-
- Cancer Genomics and Diagnostics 13
- Co-authors
- Alexandre de la TailleLuca CindoloJean‐Jacques PatardWalter ArtibaniVincenzo FicarraPeter F.A. MuldersGuorong LiAnne Gentil‐Perret
In The Last Decade
Jacques Tostain
71 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Pulmonary and Respiratory Medicine 3.3k
- Cancer Research 1.1k
- Molecular Biology 2.5k
- Surgery 1.2k
- Oncology 667
Countries citing papers authored by Jacques Tostain
This map shows the geographic impact of Jacques Tostain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Tostain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Tostain more than expected).
Fields of papers citing papers by Jacques Tostain
This network shows the impact of papers produced by Jacques Tostain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Tostain. The network helps show where Jacques Tostain may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jacques Tostain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapy. | 2012 | 21 |
| 2 | 2012 | 7 | |
| 3 | 2010 | 108 | |
| 4 | 2009 | 5 | |
| 5 | 2008 | 177 | |
| 6 | 2008 | 33 | |
| 7 | 2008 | 45 | |
| 8 | 2008 | 55 | |
| 9 | 2008 | 95 | |
| 10 | 2008 | 58 | |
| 11 | 2007 | 67 | |
| 12 | 2007 | 103 | |
| 13 | 2007 | 27 | |
| 14 | 2007 | 28 | |
| 15 | 2007 | 20 | |
| 16 | 2007 | 25 | |
| 17 | 2006 | 84 | |
| 18 | 2005 | 35 | |
| 19 | 2005 | 56 | |
| 20 | 2005 | 44 |
About Jacques Tostain
Jacques Tostain is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Medical Laboratory Technology, Surgery and Molecular Biology, having authored 72 papers that have together received 4.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (56 papers), Renal and related cancers (36 papers), Bladder and Urothelial Cancer Treatments (21 papers), Cancer Genomics and Diagnostics (13 papers), Multiple and Secondary Primary Cancers (8 papers), Pancreatic and Hepatic Oncology Research (6 papers), Hormonal and reproductive studies (4 papers) and Enzyme function and inhibition (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.3k citations), Cancer Research (1.1k citations), Molecular Biology (2.5k citations), Surgery (1.2k citations) and Oncology (667 citations). Jacques Tostain has collaborated with scholars based in France, Italy and Canada. Frequent co-authors include Alexandre de la Taille, Luca Cindolo, Jean‐Jacques Patard, Walter Artibani, Vincenzo Ficarra, Peter F.A. Mulders, Guorong Li, Anne Gentil‐Perret, Richard Zigeuner and F. Guillé. Their work appears in journals such as The Journal of Urology, European Urology, Cancer, British Journal of Urology and Fertility and Sterility.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.